Open an account Help & support Register Account summary Log out
Skip Header
Home Stock market news

Important information: The value of investments can go down as well as up so you may get back less than you invest. Investors should note that the views expressed may no longer be current and may have already been acted upon. This is a third-party news feed and may not reflect Fidelity’s views.

Smiths Group to sell Smiths Interconnect to Molex

Thu 16 Oct 2025 19:39

(Sharecast News) - Engineer Smiths Group said on Thursday that it has agreed to sell Smiths Interconnect to Molex, a Koch company, for an enterprise value of £1.3bn. Smiths said the sale, which is due to complete in the second half of fiscal 2026, is "a notable step forward" in the strategy to become a more focused industrial engineering company.

Chief executive Roland Carter said: "This is an important step as we deliver on our commitment to focus Smiths and unlock the inherent value in our business. Today's announcement, and our recent results, show we are delivering on our strategy with pace and purpose and I am confident that we will continue to do so as we further focus our business as a high-performing industrial engineering company.

"We thank our Smiths Interconnect colleagues for their significant contribution to the Smiths Group over many years and wish them every success as they transition to their new owner, Molex, who is well placed to support their future growth."

Smiths Interconnect provides of innovative solutions for critical semiconductor test applications.

Jefferies said Smiths has achieved "a good price", representing "a FY25 EV/EBITDA of 15x".

Share this article

Related Sharecast Articles

Fri 17 Jul 2026 12:40
ConocoPhillips to buy 42% stake in BP Iraq oil fields
(Sharecast News) - BP said on Friday that it has agreed terms for ConocoPhillips to buy a 42% interest in BP Energy Company of Kirkuk (BP ECKL).
Fri 17 Jul 2026 11:29
GSK shares fall as cough drug development axed
(Sharecast News) - Shares in GSK fell sharply on Friday after the pharma titan announced it was stopping the development of a refractory chronic cough drug after unsuccessful results late-stage clinical trial.
Fri 17 Jul 2026 11:26
Deutsche Bank downgrades Rotork after ABB takeover
(Sharecast News) - Deutsche Bank downgraded Rotork on Friday to 'hold' from 'buy' and lifted the price target to 503p from 400p after it agreed to be bought by Swiss engineering firm ABB in a £4.1bn deal.
Fri 17 Jul 2026 09:30
Wise Q1 revenues rise as customer numbers grow
(Sharecast News) - Wise reported an increase in first-quarter revenue on Friday as customer numbers at the money transfer firm rose.

Important information: This information is not a personal recommendation for any particular investment. If you are unsure about the suitability of an investment you should speak to one of Fidelity’s advisers or an authorised financial adviser of your choice. When you are thinking about investing in shares, it’s generally a good idea to consider holding them alongside other investments in a diversified portfolio of assets. Past performance is not a reliable indicator of future returns.

Policies and important information
 

Accessibility | Conflicts of interest statement | Consumer Duty Target Market | Consumer Duty Value Assessment Statement | Cookie policy | Diversity, Equity & Inclusion | Diversity, Equity & Inclusion Reports | Doing Business with Fidelity | Investing in Fidelity funds | Legal information | Modern slavery | Mutual respect policy | Privacy statement | Remuneration policy | Staying secure | Statutory and Regulatory disclosures | Whistleblowing programme

 

Please remember that past performance is not necessarily a guide to future performance, the performance of investments is not guaranteed, and the value of your investments can go down as well as up, so you may get back less than you invest. When investments have particular tax features, these will depend on your personal circumstances and tax rules may change in the future. This website does not contain any personal recommendations for a particular course of action, service or product. You should regularly review your investment objectives and choices and, if you are unsure whether an investment is suitable for you, you should contact an authorised financial adviser. Before opening an account, please read the ‘Doing Business with Fidelity’ document which incorporates our client terms. Prior to investing into a fund, please read the relevant key information document or Product Summary document which contains important information about the fund.

This website is issued by Financial Administration Services Limited, which is authorised and regulated by the Financial Conduct Authority (FCA) (FCA Register number 122169) and registered in England and Wales under company number 1629709 whose registered address is Beech Gate, Millfield Lane, Lower Kingswood, Tadworth, Surrey, KT20 6RP.

© FIL Limited 2026